Ngenla Європейський Союз - італійська - EMA (European Medicines Agency)

ngenla

pfizer europe ma eeig - somatrogon - growth and development - l'ipofisi e l'ipotalamo gli ormoni e farmaceutici - indicated for the long-term treatment of paediatric patients with growth disturbance due to insufficient secretion of growth hormone.